Year: 2025
Type: article
Abstract: The Standardized Outcomes in Nephrology-Transplantation (SONG-Tx) international consensus process, involving patients, caregivers and health professionals, identified cancer as a core outcome for kidney transplant trials1. Transplant recipients experience a 2-3-fold increased risk of cancer and cancer death compared to their age- and sex-matched peers2,3. The increased risk of cancer is largely attributed to the effects of long-term immunosuppression, which impairs immune surveillance and immunity to oncogenic viruses4.
Source: Kidney International Reports
Authors: Ellen Dobrijevic, Anita van Zwieten, Allison Jaure, Amy von Huben, Martin Howell, Armando Teixeira-Pinto, Sergio A. Acuna, Curie Ahn, Christopher D. Blosser, Jonathan C. Craig, Bianca Davidson, Anna Francis, Kenar D. Jhaveri, Jolanta Malyszko, Kenneth A. Newell, Alejandra Mena-Gutierrez, Naoka Murakami, Nicole Scholes-Robertson, Helio Tedesco Silva, Germaine Wong
Institutions: The University of Sydney, Children's Hospital at Westmead, Westmead Hospital, University of Alabama at Birmingham, UAB Medicine, Seoul National University, Seattle Children's Hospital, University of Washington, Flinders University, University of Cape Town, Groote Schuur Hospital, Children's Health Queensland Hospital and Health Service, Children's Hospital Foundation, Northwell Health, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, Medical University of Warsaw, Emory University, Wake Forest University Health Sciences, Wake Forest University, Washington University in St. Louis, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo
Language: English
Subfield: Transplantation
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,800
OpenAlex ID: W4412447197